Oral Drug Blocks SARS-CoV-2 Transmission in Ferrets

  • Author: ChemistryViews.org
  • Published: 09 December 2020
  • Copyright: Wiley-VCH GmbH
thumbnail image: Oral Drug Blocks SARS-CoV-2 Transmission in Ferrets

The COVID-19 pandemic is caused by the coronavirus SARS-CoV-2. Drugs for the treatment of this disease are urgently needed. The antiviral compound EIDD-2801 (also called molnupiravir or MK-4482, pictured) is a potential drug candidate against COVID-19 and is currently in phase II/III clinical trials. The drug has been repurposed—originally, it was designed as a ribonucleoside analogue inhibitor of influenza viruses.


Richard K. Plemper, Georgia State University, Atlanta, USA, and colleagues have found that EIDD-2801 can reduce the viral load in the upper respiratory tract and suppress virus transmission in ferrets. The team considers ferrets a good model because the animals can readily spread the virus, but generally do not develop severe disease—similar to young human adults. The team infected ferrets with SARS-CoV-2 and started treatment with EIDD-2801 when the animals began to shed virus from the nose. The infected, treated animals were co-housed with healthy, untreated ferrets in the same cage. None of these contact animals became infected. In a control experiment, all contacts of infected, untreated ferrets became infected.


In contrast to other possible COVID-19 treatments such as remdesivir or convalescent serum, EIDD-2801 can be given orally. This could significantly simplify treatment and transmission prevention. According to the researchers, the drug could possibly help to prevent widespread community transmission of COVID-19 until vaccinations are widely available.



Also of Interest

  • Collection: SARS-CoV-2 Virus
    What we know about the new coronavirus and COVID-19

 

News: Coronavirus Drug Molnupiravir

  • 05 October 2021

Molnupiravir significantly reduces risk of hospitalization and/or death, according to Merck

thumbnail image: Coronavirus Drug Molnupiravir

News: Improved Synthesis Route for Molnupiravir

  • 04 August 2021

Efficient synthesis from cheap and easily available cytidine

thumbnail image: Improved Synthesis Route for Molnupiravir

Research Highlight: How Molnupiravir Causes SARS-CoV-2 to Mutate and Die

  • 07 September 2021
  • Author: Roswitha HarrerORCID iD

Mechanism might apply to various viral polymerases and could explain broad-spectrum antiviral activity of molnupiravir

thumbnail image: How Molnupiravir Causes SARS-CoV-2 to Mutate and Die

News: High-Yielding Synthesis of Antiviral Drug Candidate

  • 19 November 2020

Improved preparation of EIDD‐2801, currently in clinical trials for COVID-19 treatment

thumbnail image: High-Yielding Synthesis of Antiviral Drug Candidate

News: Oral Drug Blocks SARS-CoV-2 Transmission in Ferrets

  • 09 December 2020

Repurposed ribonucleoside analogue inhibitor of influenza viruses

thumbnail image: Oral Drug Blocks SARS-CoV-2 Transmission in Ferrets

 

 

 

Article Views: 2059

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH